Home » Topics » BioWorld Science

BioWorld Science
RSS

Alector initiates first-in-human study of AL-003 for Alzheimer's disease

April 3, 2019

Stoke Therapeutics divulges new antisense oligomers

April 3, 2019

Dragonfly Therapeutics patents NKG2D-binding proteins for cancer

April 3, 2019

eFFECTOR Therapeutics candidate targets RNA helicase eIF4A for cancer

April 3, 2019

Bispecific molecule PRS-342 shows robust in vitro and in vivo antitumoral effects

April 3, 2019

Monoclonal antibody against CLDN18.2 shows development potential for gastric cancer

April 3, 2019

Decreased intraocular inflammation observed in MAPLE wet AMD study of abicipar

April 3, 2019

Novel series of reversible USP7 inhibitors as oncolytic drugs presented

April 3, 2019

Fish slime helps turn the tide against antibiotic resistance

April 3, 2019

New Alzheimer's disease model differentiates the role of C99 from beta-amyloid

April 3, 2019

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...